Reuters logo
BRIEF-Vtv Therapeutics initiates phase 1b/2 study
2017年11月8日 / 晚上10点06分 / 12 天前

BRIEF-Vtv Therapeutics initiates phase 1b/2 study

Nov 8 (Reuters) - Vtv Therapeutics Inc:

* Vtv Therapeutics Inc - ‍vtv Therapeutics initiates phase 1B/2 study evaluating TTP399 for treatment of type 1 diabetes​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below